Headed to the NCPA 2019 Annual Convention & Expo? Cannabis and the Role of the Pharmacist Plan to Attend the PPSI Breakfast Symposium 4.0 CE hrs Saturday, October 26, 2019 7 a.m. - 12:30 p.m Marriott Marquis San Diego Salon C Ballroom Registration Fees: FREE for PPSI Supporters $299 - Healthcare Professional $50 - [...]
CBD Update: Having the Facts To Answer Your Patient's Questions NOW ON-DEMAND $50 for ACA, ACVP, or PPSI Members, $25 for Student & Technician Members; $75 for non-members Recently, it has become almost impossible to pick-up the newspaper or watch the evening news without seeing a story, advertisement, or a "medical professional" [...]
Public Health Town Hall & Breakfast Pharmacists Planning Service, Inc. (PPSI) and ACA Foundation (ACA), in conjunction with California Pharmacists Association (CPhA), Pharmacy Defense Fund (PDF), and Independent Pharmacists Association (IPA) Present the 27th Annual William R. Bacon Memorial Breakfast & Public Health Town Hall Meeting Sunday, April 14, 2019 7:00 AM - [...]
http://www.marinij.com/general-news/20170215/marin-marijuana-legalization-debated-on-ij-forums Don Carney says he prefers to call the legalization of marijuana the “corporatization” of cannabis. That’s because, as laws are relaxed and it becomes more readily available, the active ingredient — tetrahydrocannabinol, or THC — is working its way into all kinds of consumer products, says Carney, director of restorative services and the Marin [...]
Top-three recognition for 14th straight year shows importance of pursuing a pro-pharmacy, pro-patient policy agenda, NACDS says 12.21.2016 "The takeaway for policymakers is that the pharmacist-patient relationship has tremendous potential to do even more to improve patient health and well-being, along with the overall quality and affordability of healthcare." click here to read the story
The Bureau of Medical Cannabis Regulation (BMCR) and Office of Medical Cannabis Safety (OMCS) will be holding their first pre-regulatory stakeholder meetings this September and October. Discussing issues related to general licensing requirements, and specific concepts related to the regulation of medical cannabis dispensaries, distributors, manufacturers, testing laboratories and transporters. Please join us for one of [...]
PPSI would like to testify in Santa Rosa on September 22, from 2-3 PM PPSI would like to testify on determining standards for packaging, labeling, dosing, potency of medical cannabis, produced as medicine, food, botanical and edibles, labeling, dosing, package contents, public health safety warnings, safety standards, cautions and public; (to mental and physical health [...]
Regarding marijuana/MMJ and mental illness, drug interactions and also, warnings that ASAM, AMA, CMA and CPhA, along with the new California Medical Marijuana Safety Act, (MMSA) ASAM says in their latest research paper, that no one under 25 should be using MJ/MMJ, due to the fact that the brain is still developing until 25 years of [...]
5 reasons marijuana is not medicine By Bertha Madras April 29 at 12:14 PM Harvard Medical School Each week, In Theory takes on a big idea in the news and explores it from a range of perspectives. This week, we’re talking about drug scheduling. Need a primer? Catch up here. Bertha Madras is a professor of psychobiology at [...]
Here is the latest from FDA-including 13 FDA citations on false advertising for cannabis, along with testimony for Congress, etc. Science of Botanicals Douglas C. Throckmorton, M.D. Food and Drug Administration (FDA) ICSB/ASP Joint Meeting April 12, 2016
